Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 567

1.

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

Vijan S, Hayward RA; American College of Physicians..

Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.

PMID:
15096337
2.

Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB; Clinical Efficacy Assessment Subcommittee of the American College of Physicians..

Ann Intern Med. 2004 Apr 20;140(8):644-9.

PMID:
15096336
3.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
4.
5.

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

Huang ES, Meigs JB, Singer DE.

Am J Med. 2001 Dec 1;111(8):633-42.

PMID:
11755507
6.

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group..

Diabetes Care. 2003 Oct;26(10):2713-21.

PMID:
14514569
7.

Management of lipid disorders in the elderly.

Playford DA, Watts GF.

Drugs Aging. 1997 Jun;10(6):444-62. Review.

PMID:
9205850
8.

Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.

Udawat H, Goyal RK.

Indian Heart J. 2001 Mar-Apr;53(2):172-6.

PMID:
11428472
9.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
10.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
11.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
12.

Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.

Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C; German Diabetes and Dialysis Study Investigators..

Am J Kidney Dis. 2009 Nov;54(5):902-11. doi: 10.1053/j.ajkd.2009.06.029.

PMID:
19781835
13.

A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

Tuomilehto J, Leiter LA, Kallend D.

Int J Clin Pract Suppl. 2004 Oct;(143):30-40. Review.

PMID:
16035394
15.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program..

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
16.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program..

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

17.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute.; American College of Cardiology Foundation.; American Heart Association..

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

18.

Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study.

Alemao E, Yin D, Sintonen H, Salomaa V, Jousilahti P.

Am J Cardiovasc Drugs. 2006;6(5):349-55.

PMID:
17083270
19.
20.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
Items per page

Supplemental Content

Support Center